PHENOXYPROPAZINE AND CHLORDIAZEPOXIDE IN DEPRESSION
Abstract
The value of phenoxypropazine in reactive depressions with prominent anxiety was investigated by comparing the effect of phenoxypropazine plus chlordiazepoxide with that of chlordiazepoxide alone on 60 outpatients. The outcome of patients on the combined treatment was good and significantly better than those receiving chlordiazepoxide only. Subjects with a good previous personality responded best to both treatments, more doing so with phenoxypropazine than without. Those with poor personalities showed only a moderate response to the combined treatment and virtually none to chlordiazepoxide alone. It is concluded that phenoxypropazine is an effective antidepressant drug which when given with chlordiazepoxide forms a useful therapy for depressions of a reactive nature.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
